Recombinant lispro insulin biosimilar (Gan & Lee)
重组赖脯胰岛素生物类似药（甘李药业）
Report date: 2023/10/11 16:47:52
Base Information
Drug NameRecombinant lispro insulin biosimilar (Gan & Lee)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2006/01/19
Country/Territory +[4]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGan & Lee Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesGan & Lee Pharmaceuticals
Inactive CompaniesGan And Lee Pharmaceuticals, Usa
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A